Lorenzo Daniele

Summary

Affiliation: University of Turin
Country: Italy

Publications

  1. doi request reprint Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancer
    Lorenzo Daniele
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    J Thorac Oncol 4:684-8. 2009
  2. doi request reprint Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases
    Paola Cassoni
    Department of Biomedical Sciences and Oncology, University of Turin, Turin, Italy
    Histopathology 55:20-7. 2009
  3. doi request reprint Neoadjuvant chemo-radiotherapy for locally advanced esophageal cancer: a monocentric study
    Marina Schena
    Department of Onco Hematology, Oncology Unit, San Giovanni Battista Hospital, Turin, Italy
    Tumori 98:451-7. 2012
  4. doi request reprint Gefitinib (ZD1839): therapy in selected patients with non-small cell lung cancer (NSCLC)?
    Diego Dongiovanni
    Medical Oncology, Centro Oncologico Ematologico Subalpino C O E S, Azienda Ospedaliera S Giovanni Battista, Turin, Italy
    Lung Cancer 61:73-81. 2008
  5. doi request reprint Technical limits of comparison of step-sectioning,immunohistochemistry and RT-PCR on breast cancer sentinel nodes: a study on methacarn-fixed tissue
    Lorenzo Daniele
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    J Cell Mol Med 13:4042-50. 2009
  6. doi request reprint Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases
    Marco Volante
    Department of Clinical and Biological Sciences, University of Turin at San Luigi Hospital, Orbassano, Turin, Italy
    Am J Surg Pathol 37:606-12. 2013
  7. doi request reprint Added value of combined gene and protein expression of CK20 and CEA in non-macroscopically involved lymph nodes of colorectal cancer
    Giuseppe D'Armento
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    Int J Surg Pathol 17:93-8. 2009
  8. doi request reprint Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines
    Daniele Recupero
    Department of Biomedical Sciences and Human Oncology, University of Turin, Via Santena 7, Turin, Italy
    J Pathol 229:390-9. 2013
  9. ncbi request reprint Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens
    Lorenzo Daniele
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    Mol Cancer Ther 6:1223-9. 2007
  10. doi request reprint Imatinib inhibits in vitro proliferation of cells derived from a pleural solitary fibrous tumor expressing platelet-derived growth factor receptor-beta
    Marco Prunotto
    Department of Biomedical Science and Human Oncology, University of Turin, Italy
    Lung Cancer 64:244-6. 2009

Collaborators

Detail Information

Publications14

  1. doi request reprint Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancer
    Lorenzo Daniele
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    J Thorac Oncol 4:684-8. 2009
    ..Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors are capable of reducing brain and adrenal metastases. However, the EGFR status may be discordant between primary NSCLC and the corresponding metastases...
  2. doi request reprint Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases
    Paola Cassoni
    Department of Biomedical Sciences and Oncology, University of Turin, Turin, Italy
    Histopathology 55:20-7. 2009
    ..To study caveolin-1 (Cav-1) expression in metastatic lung carcinomas...
  3. doi request reprint Neoadjuvant chemo-radiotherapy for locally advanced esophageal cancer: a monocentric study
    Marina Schena
    Department of Onco Hematology, Oncology Unit, San Giovanni Battista Hospital, Turin, Italy
    Tumori 98:451-7. 2012
    ....
  4. doi request reprint Gefitinib (ZD1839): therapy in selected patients with non-small cell lung cancer (NSCLC)?
    Diego Dongiovanni
    Medical Oncology, Centro Oncologico Ematologico Subalpino C O E S, Azienda Ospedaliera S Giovanni Battista, Turin, Italy
    Lung Cancer 61:73-81. 2008
    ....
  5. doi request reprint Technical limits of comparison of step-sectioning,immunohistochemistry and RT-PCR on breast cancer sentinel nodes: a study on methacarn-fixed tissue
    Lorenzo Daniele
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    J Cell Mol Med 13:4042-50. 2009
    ..We believe that only prospective studies with quantitative mRNA analysis of specific metastatic markers on the whole lymph node can elucidate the utility of molecular assessments of SLN...
  6. doi request reprint Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases
    Marco Volante
    Department of Clinical and Biological Sciences, University of Turin at San Luigi Hospital, Orbassano, Turin, Italy
    Am J Surg Pathol 37:606-12. 2013
    ....
  7. doi request reprint Added value of combined gene and protein expression of CK20 and CEA in non-macroscopically involved lymph nodes of colorectal cancer
    Giuseppe D'Armento
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    Int J Surg Pathol 17:93-8. 2009
    ..This approach offers a technological framework for further studies that aim to validate the clinical significance of protein/mRNA expression of tumor markers in colorectal cancer sentinel lymph nodes...
  8. doi request reprint Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines
    Daniele Recupero
    Department of Biomedical Sciences and Human Oncology, University of Turin, Via Santena 7, Turin, Italy
    J Pathol 229:390-9. 2013
    ..Our data suggest that a reduction of the receptor steric hindrance as induced by enzymatic shedding may facilitate the binding capacity of trastuzumab...
  9. ncbi request reprint Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens
    Lorenzo Daniele
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    Mol Cancer Ther 6:1223-9. 2007
    ....
  10. doi request reprint Imatinib inhibits in vitro proliferation of cells derived from a pleural solitary fibrous tumor expressing platelet-derived growth factor receptor-beta
    Marco Prunotto
    Department of Biomedical Science and Human Oncology, University of Turin, Italy
    Lung Cancer 64:244-6. 2009
    ..With the limit of experimental findings, our results support a possible future application of imatinib as a candidate molecule in the target therapy of malignant SFTs over-expressing wild-type PDGFR...
  11. doi request reprint Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms
    Enrico Ruffini
    Department of Thoracic Surgery, University of Torino, Torino, Italy
    Ann Thorac Surg 87:365-71; discussion 371-2. 2009
    ..We examined prevalence, correlations, and prognostic significance of TIL among our patient population of resected lung neoplasms...
  12. doi request reprint Columnar cell lesions associated with breast calcifications on vacuum-assisted core biopsies: clinical, radiographic, and histological correlations
    Rebecca Senetta
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    Mod Pathol 22:762-9. 2009
    ....
  13. ncbi request reprint Anti-HER2 treatment and breast cancer: state of the art, recent patents, and new strategies
    Lorenzo Daniele
    Department of Biomedical Sciences and Human Oncology, University of Turin, Italy
    Recent Pat Anticancer Drug Discov 4:9-18. 2009
    ..This review will focus on patents that target HER2 in anti-cancer treatment...
  14. doi request reprint Metastasis of malignant peritoneal epithelioid mesothelioma in endoscopic gastric biopsy: a diagnostic pitfall
    Lorenzo Daniele
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    Int J Surg Pathol 19:217-9. 2011
    ....